<SEC-DOCUMENT>0001279569-18-002390.txt : 20181203
<SEC-HEADER>0001279569-18-002390.hdr.sgml : 20181203
<ACCEPTANCE-DATETIME>20181203111925
ACCESSION NUMBER:		0001279569-18-002390
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20181203
FILED AS OF DATE:		20181203
DATE AS OF CHANGE:		20181203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AURORA CANNABIS INC
		CENTRAL INDEX KEY:			0001683541
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38691
		FILM NUMBER:		181213207

	BUSINESS ADDRESS:	
		STREET 1:		1500 - 1199 WEST HASTINGS ST.
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E 3T5
		BUSINESS PHONE:		604-362-5207

	MAIL ADDRESS:	
		STREET 1:		1500 - 1199 WEST HASTINGS ST.
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E 3T5
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>aurora_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>UNITED
STATES</B></FONT><BR>
<FONT STYLE="font-size: 14pt"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT><BR>
<B>Washington, D.C. 20549</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: center"><B>RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">For the month of <B>December 2018</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">Commission File No. <B>001-38691</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 24pt"><B>AURORA
CANNABIS INC.</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 70%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: center"><FONT STYLE="font-size: 24pt"></FONT><BR>
<FONT STYLE="font-size: 10pt">(Translation of registrant's name into English)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>500 - 10355 Jasper Avenue</B><BR>
<B>Edmonton, Alberta, T5J 1Y6, Canada</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 70%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: center"><B></B><BR>
(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">Form 20-F &#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <B> Form
40-F&nbsp;&nbsp;&#9746;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) &nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) &nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>SUBMITTED HEREWITH</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; font: 12pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibits</B></FONT></TD>
    <TD STYLE="width: 2%"></TD>
    <TD STYLE="width: 90%; font: 12pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Description&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><A HREF="ex991.htm">99.1</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: bold 13pt Arial, Helvetica, Sans-Serif; text-align: left; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-transform: none"><A HREF="ex991.htm">News
    Releases dated December 3, 2018 - Aurora Cannabis Announces Market Launch of Softgel Capsules</A></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 13pt Arial, Helvetica, Sans-Serif; text-align: left; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>AURORA CANNABIS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">/s/ <I>Glen Ibbott</I></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><I></I><BR>
Glen Ibbott<BR>
Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Date: December 3, 2018</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>NEWS RELEASE DATED DECEMBER 3, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;<IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora Cannabis Announces Market Launch
of Softgel Capsules</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">TSX | NYSE: ACB</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">EDMONTON, Dec.&nbsp;3, 2018 /CNW/ -&nbsp;Aurora
Cannabis Inc. (&quot;Aurora&quot; or the &quot;Company&quot;) (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today
that, further to its October 17, 2018 announcement that it had received a sales license from Health Canada permitting the sale
of cannabis softgel capsules, the Company has commenced shipments for both the Canadian medical and adult-use markets. Aurora expects
to commence exports to international markets in early 2019.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">At scale, the Company anticipates that softgel
production at its state-of-the-art Aurora Vie facility in Quebec will reach at least 1.4 million capsules per week. Aurora intends
to make this high-volume, high-margin, smoke-free, product available to all of its domestic and international target markets over
time where legally possible.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora's softgel capsules are produced to pharmaceutical-grade
standards at Aurora Vie, in collaboration with leading softgel manufacturer Capcium Inc. (&quot;Capcium&quot;), in which Aurora
holds a 19.99% ownership interest. The Company will initially launch the capsules to the medical cannabis market in Canada as well
as the adult-use market in British Columbia with additional provincial markets to follow.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The Company is initially launching four softgel
product types, each available in bottles of 30 capsules, priced at $45 per bottle. The small, easy to digest soft gelatin capsules
are colour-coded to distinguish between the different varieties for the protection of public health and safety. They are believed
to the smallest cannabis capsules on the market. Aurora's softgels provide a dosage-controlled format that medical practitioners
and consumers around the world need to facilitate more precise administration.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">For the medical market, Aurora is launching
three product types:</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora Indica Softgels: 8-10 mg/pill of THC<BR>
Aurora Sativa Softgels: 8-10 mg/pill of THC<BR>
Aurora CBD Softgels: 8-10 mg/pill of CBD</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">For the BC consumer market, one product type
will be available initially:</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora Liquid Gels: 8-10 mg/pill of CBD, targeted
at the non-prescription wellness segment of the market</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Additional product types and potencies will
be made available in the coming months including softgel capsules that contain 5mg THC, 20mg CBD and 1:1 (5gm CBD and 5mg THC),
plus softgels that employ a range of functional carrier oils.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Management Commentary</B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;Softgels are a high-volume, high-margin
product for both the medical and adult-use markets that are in strong demand, and Aurora is one of few companies making these products
available to patients and consumers alike,&quot; said Terry Booth, CEO of Aurora. &quot;There is a strong momentum towards smoke-free,
consistent dosage delivery technologies, and our softgels are a very familiar form factor that satisfy patient and consumer needs.
We are delighted to have a preferred partnership with Capcium, whose technology is performing above our initial expectations, delivering
high volumes of pharma-grade products.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Shane Morris, SVP Product Development and Regulatory
Affairs, added, &quot;Following our successful receipt of our sales license for softgels, we are now ready to start providing yet
another type of delivery technology for our patients and customers. Production will be scaling up in the coming weeks, which will
enable us to introduce this product to all our domestic and international target markets. We will also continue to develop new
types of softgel products, broadening our offering to meet all medical and consumer needs.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Aurora&nbsp;</B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Headquartered in Edmonton, Alberta, Canada
with funded capacity in excess of 500,000 kg per annum and sales and operations in 21 countries across five continents, Aurora
is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across
every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis
and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Highly differentiated from its peers, Aurora
has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate
leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale
production of high- quality product at low cost. Intended to be replicable and scalable globally, our production facilities are
designed to produce cannabis of significant scale, with high quality, industry-leading yields, and low per gram production costs.
Each of Aurora's facilities is built to meet EU GMP standards, and its first production facility, the recently acquired MedReleaf
Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland, have achieved this level of certification.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">In addition to Aurora's rapid organic growth
and strong execution on strategic M&amp;A, which to date includes 15 wholly owned subsidiary companies &ndash; MedReleaf, CanvasRX,
Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics,
Anandia Labs, HotHouse Consulting, MED Colombia, Agropro, Borela, and ICC &ndash; Aurora is distinguished by its reputation as
a partner and employer of choice in the global cannabis sector, having invested in and established strategic partnerships with
a range of leading innovators, including: Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann
Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Capcium Inc. (private), Evio
Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), and Alcanna Inc. (TSX: CLIQ).</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora's Common Shares trade on the TSX and
NYSE under the symbol &quot;ACB&quot;, and are a constituent of the S&amp;P/TSX Composite Index.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">For more information about Aurora, please visit
our investor website, <U>investor.auroramj.com </U></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Terry Booth, CEO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
Aurora Cannabis Inc.&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Caution Concerning Forward-Looking Statements</B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">This news release includes statements containing
certain &quot;forward-looking information&quot; within the meaning of applicable securities law (&quot;forward-looking statements&quot;).
Forward-looking statements are frequently characterized by words such as &quot;plan&quot;, &quot;continue&quot;, &quot;expect&quot;,
&quot;project&quot;, &quot;intend&quot;, &quot;believe&quot;, &quot;anticipate&quot;, &quot;estimate&quot;, &quot;may&quot;, &quot;will&quot;,
&quot;potential&quot;, &quot;proposed&quot; and other similar words, or statements that certain events or conditions &quot;may&quot;
or &quot;will&quot; occur and include, but are not limited to the variety of cannabis products that Aurora will supply to the adult-use
market.. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections
contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions
and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other
factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.
The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Neither the TSX, NYSE nor their Regulation
Services Providers (as that term is defined in the policies of Toronto Stock Exchange and New York Stock Exchange) accepts responsibility
for the adequacy or accuracy of this release.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><IMG SRC="image_001.jpg" ALT="Cision" STYLE="height: 12px; width: 12px">View
original content:http://www.prnewswire.com/news-releases/aurora-cannabis-announces-market-launch-of-softgel-capsules-300758813.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SOURCE Aurora Cannabis Inc.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content: http://www.newswire.ca/en/releases/archive/December2018/03/c2795.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">%CIK: 0001683541</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For further information: </B>For Media: Heather MacGregor, (416)
509-5416, heather.macgregor@auroramj.com; For Investors: Marc Lakmaaker, (647) 269-5523, marc.lakmaaker@auroramj.com; Rob Kelly,
(647) 331-7228, rob.kelly@auroramj.com; U.S. Investors: Phil Carlson / Elizabeth Barker, KCSA Strategic Communications, (212) 896-1233
/ (212) 896-1203, pcarlson@kcsa.com / ebarker@kcsa.com</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CO: Aurora Cannabis Inc.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CNW 07:00e 03-DEC-18</P>



<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ,  P# 2(  A$! Q$!_\0
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?L94\=#@5IJH50HZ 8%8TXM3DWU.BK.+I02Z>7ZG_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  U ,L# 2(  A$! Q$!_\0
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M;MY<WM@BLQSPY_B"^Z_+GZ^QKH: "BBB@ HHHH **** "BBB@ HHHH ****
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M9TE_[-(%QY#^1]['F9&-V?W?IMW<[MN.]=K3)(HY0!(BN P8!AG!!R#]0>:
M/)_A<OB42+_;IF^T><2OG;BPCV?Q[#C/79OXQNQS7%?""XNK36O$L]DA:=;4
M8Q&9"H,P#,%'+;02<#KC%?1%K8VMD@2VMXX@%"#:O.T$D#/IDG\S6%X;\!>'
M_"=_<WND6TD4]RNR0O,SC&<X )XYH XQ[U[;58VTE+IY%8 W+.R/>/D?-(-P
M!!.< @8!QQ7J5H;@VD1NQ&+@J/,$>=H/MFIJ* *VHM=)IETUC&LEV(F,",P
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MAXICGTVT@>PMK=8H6>X5<L3EC@^^!_P&O:** /,X?@9X06WC$RWSRA0'87)
M+8Y.*YGP%\.O%WA'Q_#?M:P-INZ2"61;E<M$<[6V]<Y"G%>Y44 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
'!1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
